FindTrial
Sign In

Clinical value of procalcitonin in patients with Intensive Care Units: a multicenter study

Clinical value of procalcitonin in patients with Intensive Care Units: a multicenter study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017806
Enrollment
Unknown
Registered
2018-08-15
Start date
2018-09-20
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

critical disease

Interventions

Case series:procalcitonin

Sponsors

Huizhou Municipal Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. patients who stayed at ICU for more than 24 hours; 2. aged more than 15 years old; 3. signed informed consent.

Exclusion criteria

Exclusion criteria: 1. stay in ICU over 24 hours; 2. patients with thyroid tumors; 3. the patient has no autonomy and can not find a legal representative to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Procalcitonin;28 day mortality;90 day mortality;APACHE2 score;lactic acid;White blood cell count;ESR;IL-6;temperature;SOFA score;Charlson score;Hospitalization expenses;BMI;CRP;—

Countries

China

Contacts

Public ContactRong QU

Huizhou Municipal Central Hospital

hzqurong@126.com+86 13829912988

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026